Harry Korman - Viatris Non-Executive Independent Director
Director
Mr. Harry A. Korman serves as NonExecutive Independent Director of Mylan N.V. since 2018. Board Committees Compliance Risk Oversight Science and Technology. He held senior executive roles of increasing responsibility at Mylan Inc. and its subsidiaries from 1996 until July 2014. He served as Mylan Inc.s global Chief Operating Officer from January 2012 until July 2014, after which he served in a consultant role with Mylan Inc. for one year. Prior to his service as Chief Operating Officer, he was the President, North America of Mylan Inc. commencing in October 2007. He served as President of Mylan Pharmaceuticals Inc. from February 2005 to December 2009. During his time as an executive at Mylan, Mr. Korman was instrumental in identifying, evaluating and executing on significant commercial and business development opportunities in the United States and other countries, including the expansion of Mylans global generics businesses around the world, among many other important contributions to the Company and its stakeholders. He joined Mylan in 1996 after the Companys acquisition of UDL Laboratories, Inc., and served as its president, among other prior responsibilities. He served as a past director and vice chairman of the Generic Pharmaceutical Association, now known as the Association for Accessible Medicines. He also previously served as a director and vice chairman of the HDMA Foundation, which serves the healthcare industry by providing research and education focused on healthcare supply issues. His qualifications to serve on Mylans Board include, among others, his extensive industry and leadership experience, his knowledge of healthcare systems and the U.S. and global commercial markets, and his leadership experience in the areas of global strategy, risk oversight, sales and marketing, commercial operations, supply chain and business development, among other areas relevant and important to Mylans global business. since 2018.
| Age | 60 |
| Tenure | 6 years |
| Phone | 44 1707 853 000 |
| Web | http://www.mylan.com |
Viatris Management Efficiency
The company has Return on Asset of 3.63 % which means that on every $100 spent on assets, it made $3.63 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 2.22 %, implying that it generated $2.22 on every 100 dollars invested. Viatris' management efficiency ratios could be used to measure how well Viatris manages its routine affairs as well as how well it operates its assets and liabilities.The company has 12.51 B in debt with debt to equity (D/E) ratio of 1.0, which is OK given its current industry classification. Viatris has a current ratio of 0.99, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist Viatris until it has trouble settling it off, either with new capital or with free cash flow. So, Viatris' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Viatris sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Viatris to invest in growth at high rates of return. When we think about Viatris' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Cecil Moore | NL Industries | 81 | |
| Robert Pincus | Comstock Holding Companies | 69 | |
| Gregory Benson | Comstock Holding Companies | 58 | |
| Thomas Stafford | NL Industries | 90 | |
| Clayton Perfall | Comstock Holding Companies | 57 | |
| David Guernsey | Comstock Holding Companies | 66 | |
| Keith Coogan | NL Industries | 64 | |
| Meredith Mendes | NL Industries | 62 | |
| Terry Worrell | NL Industries | 69 | |
| James MacCutcheon | Comstock Holding Companies | 62 | |
| Norman Chirite | Comstock Holding Companies | 52 | |
| John Harper | NL Industries | 59 | |
| Joseph Squeri | Comstock Holding Companies | 48 | |
| Michael Kandris | Alto Ingredients | 76 | |
| Socrates Verses | Comstock Holding Companies | 56 | |
Management Performance
| Return On Equity | 2.22 | |||
| Return On Asset | 3.63 |
Viatris Leadership Team
Elected by the shareholders, the Viatris' board of directors comprises two types of representatives: Viatris inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Viatris. The board's role is to monitor Viatris' management team and ensure that shareholders' interests are well served. Viatris' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Viatris' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anthony Mauro, President of Mylan North America | ||
| Joseph Maroon, Independent Director | ||
| Kris King, VP of Global Investor Relations | ||
| Heather Bresch, CEO, Executive Director and Member of Science and Technology Committee | ||
| Harry Korman, Non-Executive Independent Director | ||
| Melina Higgins, Independent Director | ||
| Mark Parrish, Independent Director | ||
| Kenneth Parks, CFO | ||
| Rodney Piatt, Vice Chairman of the Board, Lead Independent Director | ||
| Rajiv Malik, President, Executive Director and Member of Science and Technology Committee | ||
| John Sheehan, Executive Vice President CFO, Principal Financial officer | ||
| Dennis Zeleny, Chief Human Resource Officer | ||
| JoEllen Dillon, Independent Director | ||
| Neil Dimick, Independent Director | ||
| Sjoerd Vollebregt, Independent Director | ||
| Douglas Leech, Independent Director | ||
| Robert Cindrich, Independent Director | ||
| Pauline Mohr, Non-Executive Independent Director | ||
| Wendy Cameron, Independent Director | ||
| Rakesh Bamzai, President - India Commercial and Emerging Markets | ||
| Robert Coury, Executive Chairman and Chairman of Executive Committee | ||
| Daniel Gallagher, Chief Legal Officer | ||
| Richard Mark, Non-Executive Independent Director | ||
| Randall Vanderveen, Independent Director |
Viatris Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Viatris a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.22 | |||
| Return On Asset | 3.63 | |||
| Profit Margin | 2.31 % | |||
| Operating Margin | 30.50 % | |||
| Current Valuation | 20.35 B | |||
| Shares Outstanding | 541.55 M | |||
| Shares Owned By Insiders | 0.91 % | |||
| Shares Owned By Institutions | 90.50 % | |||
| Number Of Shares Shorted | 47.14 M | |||
| Price To Earning | 30.73 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Viatris Stock
If you are still planning to invest in Viatris check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viatris' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |